Enteral Nutrition Support of Head and Neck Cancer Patients

Abstract

Patients with head and neck cancer are at high risk for malnutrition due to dysphagia from the tumor and treatment. Despite difficulty with oral intake, these patients usually have a normal stomach and lower gastrointestinal tract. Enteral nutrition support via percutaneous endoscopic gastrostomy (PEG) administered in the home by the patient helps to prevent weight loss, dehydration, nutrient deficiencies, treatment interruptions, and hospitalizations. It also improves quality of life. Successful management of these patients requires orderly care and follow-up by a multidisciplinary nutrition team.

Get full access to this article

View all access options for this article.

References

American Cancer Society. Cancer facts & figures 2006. Available at: http://www.cancer.org. Accessed August 1, 2006.

Bourhis J, Calais G, Lapeyre M, et al; French Head and Neck Cancer Group (GORTEC). Concomitant radiochemotherapy or accelerated radiotherapy: analysis of two randomized trials of the French Head and Neck Cancer Group (GORTEC). Semin Oncol. 2004 ;31:822– 826.

Brockstein B, Vokes EE. Concurrent chemoradiotherapy for head and neck cancer. Semin Oncol. 2004 ;31:786– 793.

Zogbaum AT, Fitz P, Duffy V. Tube feeding may improve adherence to radiation treatment schedule in head and neck cancer. Topics Clin Nutr. 2004;19:95– 106.

Lees J. Incidence of weight loss in head and neck cancer patients on commencing radiotherapy treatment at a regional oncology centre. Eur J Cancer Care. 1999 ;8:133– 136.

Mekhail TM, Adelstein DJ, Rybicki LA, Larto MA, Saxton JP, Lavertu P. Enteral nutrition during the treatment of head and neck carcinoma. Cancer. 2001;91:1785– 1790.

Hunchareck M, Kupelnick B. Combined chemoradiation versus radiation therapy alone in locally advanced nasopharyngeal carcinoma. Am J Clin Oncol. 2002;25:219– 223.

DeArruda FF, Puri DR, Zhung J. Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: the Memorial Sloan-Kettering Cancer Center experience. Int J Radiat Oncol. 2006;64:363– 373.

Brizel D, Esclamado R. Concurrent chemoradiotherapy for locally advanced, nonmetastatic, squamous carcinoma of the head and neck: consensus, controversy, and conundrum. J Clin Oncol.2006 ;24:2612– 2617.

10.

Ward EC, Bishop B, Frisby J, Stevens M. Swallowing outcomes following laryngectomy and pharyngolaryngectomy. Arch Otolaryngol Head Neck Surg. 2002;128:181– 186.

11.

Molina de Melo G, Ribeiro K, Kowalski L, Dehemzelin D. Risk factors for postoperative complications in oral cancer and their prognostic limitations. Arch Otolaryngol Head Neck Surg. 2001 ;127:828– 833.

12.

Psyrri A, Kwong M, DiStasio S, et al. Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up. J Clin Oncol. 2004;22:3061– 3069.

13.

Nguyen NP, Moltz CC, Frank C, et al. Dysphagia following chemoradiation for locally advanced head and neck cancer. Ann Oncol. 2004;15:383– 388.

14.

Larsson M, Hedelin B, Johansson I, Athlin E. Eating problems and weight loss for patients with head and neck cancer. Cancer Nurs. 2005;28:425– 435.

15.

Lotempio MM, Wang KH, Sadeghi A, Delacure MD, Juillard GF, Wang MB. Comparison of quality of life outcomes in laryngeal cancer patients following chemoradiation vs. total laryngectomy. Otolaryngol Head Neck Surg. 2005;132:948– 953.

16.

Duke RL, Campbell BH, Indresano AT, et al. Dental status and quality of life in long-term head and neck cancer survivors. Laryngoscope. 2005 ;115:678– 683.

17.

Brizel DM, Wasserman TH, Henke M, et al. Phase III randomized trial of amifostine as a radioprotector in head and neck cancer. J Clin Oncol. 2000;18:3339– 3345.

18.

Rose-Ped AM, Bellm LA, Epstein JB, Trotti A, Gwede C, Fuchs HJ. Complications of radiation therapy for head and neck cancers. Cancer Nurs. 2002 ;25:461– 467.

19.

Abendstein H, Nordgren M, Boysen M. Quality of life and head and neck cancer: a 5 year prospective study. Laryngoscope. 2005 ;115:2183– 2192.

20.

Laurell G, Kraepelien T, Mavroidis P, et al. Stricture of the proximal esophagus in head and neck carcinoma patients after radiotherapy. Cancer. 2003;97:1693– 1700.

21.

Maguire PD, Meyerson MB, Neal CR, et al. Toxic cure: hyperfractionated radiotherapy with concurrent cisplatin and fluorouracil for stage III, and IVA head-and-neck cancer in the community. Int J Radiat Oncol Biol Physiol. 2004 ;58:698– 704.

22.

Sullivan CA, Jaklitsch MT, Haddad R, et al. Endoscopic management of hypopharyngeal stenosis after organ sparing therapy for head and neck cancer. Laryngoscope. 2004 ;114:1924– 1931.

23.

Bueno R, Swanson S, Jaklitsch M, Lukanich JM, Mentzer SJ, Sugarbaker DJ. Combined antegrade and retrograde dilation: a new endoscopic technique in the management of complex esophageal obstruction. Gastrointest Endosc. 2001 ;54:368– 372.

24.

Lew R, Shah J, Chalian A, Weber RS, Williams NN, Kochman ML. Technique of endoscopic retrograde puncture and dilatation of total esophageal stenosis in patients with radiation-induced strictures. Head Neck. 2004;26:179– 183.

25.

Kaufman J, Schattner M, Wong R, et al. Outcome of endoscopic management of complete cervical esophageal obstruction [abstract]. Gastrointest Endosc.2006 ;63:AB245 .

26.

Beaver MS, Matheny KE, Roberts DB, Myers JN. Predictors of weight loss during radiation therapy. Otolaryngol Head Neck Surg. 2001;125:645– 648.

27.

Schattner M. Enteral nutritional support of the patient with cancer: route and role. J Clin Gastroenterol.2003 ;36:297– 302.

28.

Newman LA, Vieira F, Schwiezer V, et al. Eating and weight changes following chemoradiation therapy for advanced head and neck cancer. Arch Otolaryngol Head Neck Surg. 1998 ;124:589– 592.

29.

Mick R, Vokes EE, Weichselbaum RR, Panje WR. Prognostic factors in advanced head and neck cancer patients undergoing multimodality therapy. Otolaryngol Head Neck Surg. 1991 ;105:62– 73.

30.

Raykher A, Schattner M, Friedman A, et al. Safety and efficacy of pretreatment placement of PEG tubes in head and neck cancer patients undergoing chemoradiation treatment. Clin Nutr.2004 ;23:757 .

31.

Lee JH, Machtay M, Unger LD. Prophylactic gastrostomy tubes in patients undergoing intensive irradiation for cancer of the head and neck. Arch Otolaryngol Head Neck Surg. 1998 ;124:871– 875.

32.

Scolapio JS, Spangler PR, Romano MM, McLaughlin MP, Salassa JR. Prophylactic placement of gastrostomy feeding tubes before radiotherapy in patients with head and neck cancer. J Clin Gastroenterol. 2001;22:215– 217.

33.

Loser C, Wolters S, Folsch UR. Enteral long-term nutrition via percutaneous endoscopic gastrostomy (PEG) in 210 patients. Dig Dis Sci. 1998 ;43:2549– 2557.

34.

Anwander T, Berge S, Appel T, et al. Percutaneous endoscopic gastrostomy for long-term feeding of patients with oropharyngeal tumors. Nutr Cancer. 2004 ;50:40– 45.

35.

Lees J. Nasogastric and percutaneous endoscopic gastrostomy feeding in head and neck cancer patients receiving radiotherapy treatment at a regional oncology unit: a two year study. Eur J Cancer Care. 1997;6:45– 49.

36.

Magne N, Marcy PY, Foa C, et al. Comparison between nasogastric tube feeding and percutaneous endoscopic gastrostomy in advanced head and neck cancer patients. Eur Arch Otorhinolaryngol. 2001 ;258:89– 92.

37.

McClave SA, Chang W. Complications of enteral access. Gastrointest Endosc. 2003 ;58:739– 751.

38.

Shike M. Enteral feeding. In: Shills M, Shike M, Ross AC, Caballero B, Cousins RJ, eds. Modern Nutrition in Health and Disease. 10^th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2005:1555 .

39.

Cosentini EP, Sautner T, Gnant M, Winkelbauer F, Teleky B, Jakesz R. Outcomes of surgical, percutaneous endoscopic and percutaneous radiologic gastrostomies. Arch Surg. 1998 ;133:1076– 1083.

40.

Scott JS, de la Torre RA, Unger SW. Comparison of operative versus percutaneous endoscopic gastrostomy tube placement in the elderly. Am Surg. 1991;57:338– 340.

41.

Stern JS. Comparison of percutaneous endoscopic gastrostomy with surgical gastrostomy at a community hospital. Am J Gastroenterol. 1986;81:1171– 1173.

42.

Larson DE, Burton DD, Schroeder KW, Di Mango EP. Percutaneous endoscopic gastrostomy: indications, success, complications, and mortality in 314 consecutive patients. Gastroenterology. 1987 ;93:48– 52.

43.

Pender SM, Courtney MG, Rajan E, McAdam B, Fielding JF. Percutaneous endoscopic gastrostomy: results of an Irish single unit series. Ir J Med Sci. 1993 ;162:452– 455.

44.

Fox MR, Harris AW. An assessment of open access referral for percutaneous endoscopic gastrostomy in a district general hospital. Eur J Gastroenterol Hepatol. 2002 ;14:1245– 1249.

45.

Shike M, Berner YN, Gerdes H, et al. Percutaneous endoscopic gastrostomy and jejunostomy for long term enteral feeding in patients with cancer of the head and neck. Otolaryngol Head Neck Surg. 1989;101:549– 554.

46.

Vanek VW. Ins and outs of enteral access, part 2: long term access. Nutr Clin Pract. 2003 ;18:50– 74.

47.

Ponsky JL, Gauderer MWL, Stellato TA. Percutaneous endoscopic gastrostomy. Arch Surg. 1983 ;118:913– 914.

48.

Rabeneck L, Wray NP, Petersen NJ. Long-term outcomes of patients receiving percutaneous endoscopic gastrostomy tubes. J Gen Intern Med. 1996;11:287– 293.

49.

Amann W, Mischinger HJ, Berger A, et al. Percutaneous endoscopic gastrostomy (PEG): 8 years of clinical experience in 232 patients. Surg Endosc.1997 ;11:741– 744.

50.

Grant JP. Percutaneous endoscopic gastrostomy: initial placement by single endoscopic technique and long-term follow-up. Ann Surg. 1993;217:168– 174.

51.

Dwyer KM, Watts DD, Thurber JS, Benoit RS, Fakhry SM. Percutaneous endoscopic gastrostomy: the preferred method of elective feeding tube placement in trauma patients. J Trauma. 2002 ;52:26– 32.

52.

Baskin WN. Acute complications associated with bedside placement of feeding tubes. Nutr Clin Pract. 2006 ;21:40– 55.

53.

Schattner M, Barrera R, Nygard S, et al. Outcome of home enteral nutrition in patients with malignant dysphagia. Nutr Clin Pract. 2001;16:292– 295.

54.

Shike M, Wallach C, Gerdes H, Hermann-Zaidinns M. Skin-level gastrostomies and jejunostomies for long-term enteral feeding. JPEN J Parenter Enteral Nutr. 1989 ;13:648– 650.

55.

Schattner M, Willis H, Raykher A, et al. Long term enteral nutrition facilitates optimization of body weight. JPEN J Parenter Enteral Nutr. 2005;29:198– 203.

56.

Hull MA, Rawlings J, Murray FE, et al. Audit of outcomes of long-term enteral nutrition by percutaneous endoscopic gastrostomy. Lancet. 1993;341:869– 897.

57.

Howard L, Patton L. Outcome of long-term enteral feeding. Gastrointest Endosc Clin North Am. 1998 ;8:705– 723.

58.

Abitbol A, Abdel-Wahab MAS, Harvey M. Phase II study of tolerance and efficacy of hyperfractionated radiation therapy and 5-fluorouracil, cisplatin, and paclitaxel and amifostine in head and neck squamous cell carcinomas. Am J Clin Oncol. 2005 ;28:449– 455.

59.

Crosby J, Duerkesen D. A retrospective survey of tube-related complications in patients receiving long-term home enteral nutrition. Dig Dis Sci. 2005 ;50:1712– 1717.

60.

Pearce CB, Duncan HD. Enteral feeding: nasogastric, nasojejunal, percutaneous endoscopic gastrostomy, or jejunostomy: its indications and limitations. Postgrad Med. 2002 ;78:198– 204.

61.

Hammerlid E, Bjordal K, Ahlmer-Elmqvist M, et al. A prospective study of quality of life in head and neck cancer patients, part I: at diagnosis. Laryngoscope. 2001 ;111:669– 680.

62.

Senft M, Fietkau R, Iro H, Sailer D, Sauer R. The influence of supportive nutritional therapy via percutaneous endoscopically guided gastrostomy on the quality of life of cancer patients. Support Care Cancer. 1993;1:272– 275.

63.

Klose J, Heldwein W, Rafferzeder M, Sernetz F, Gross M, Loeschke K. Nutritional status and quality of life with percutaneous endoscopic gastrostomy (PEG) in practice: prospective one-year follow up. Dig Dis Sci. 2003;48:2057– 2063.